Antibody Industrial Symposium (AIS)
This year’s AIS will focus on therapeutic antibodies & derivatives formats, Ab-like molecules, adoptive cell therapy and other innovative advanced therapy medicinal products (ATMPs) for fighting diseases.
Diogo Rodrigues Ferreirinha, Retrogenix’s European Business Development Manager, will be presenting at the meeting – which will be run digitally due to the pandemic.
Diogo will contribute to the session focusing on “Enhancing Immunotherapy Efficacy and Safety: New Preclinical Models”. His talk is titled:
“Specificity screening of biotherapeutics against extensive libraries of plasma membrane and secreted protein targets”
If you are not able planning on participating in this virtual meeting, but would like to hear more about this topic then please do get in touch with a member of our team.